Form 4: Actinium Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Richard I Steinhart, a Director of Actinium Pharmaceuticals, Inc., reported multiple transactions in common stock on September 2, 2026.
Summary
- Grant/award: acquired 62,800 Common Stock on September 2, 2026; holds 63,116 after (Direct).
- Grant/award: acquired 94,200 Stock Option (Right to Buy) on September 2, 2026; holds 94,200 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Richard I Steinhart — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Grant/award | Common Stock | 62,800 | — | — | 63,116 |
| 2026-09-02 | Grant/award | Stock Option (Right to Buy) | 94,200 | — | — | 94,200 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Grant/award (62,800 shares) |
| 2026-09-02 | Grant/award (94,200 shares) |
Keywords
insider transaction, Form 4, ATNM, Actinium Pharmaceuticals, Inc., neutral, Richard I Steinhart
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.